Aquestive Therapeutics, Inc. (AQST) Operating margin 2017–2025
Aquestive Therapeutics, Inc. (AQST) operating margin by fiscal year — reported operating income divided by reported revenue.
-159.5%FY2025 · since FY2017: -0.2% → -159.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -159.5% | -106.0 pp |
| FY2024 | -53.5% | -23.6 pp |
| FY2023 | -29.9% | +58.4 pp |
| FY2022 | -88.2% | -20.0 pp |
| FY2021 | -68.2% | +25.3 pp |
| FY2020 | -93.6% | +6.6 pp |
| FY2019 | -100.1% | -27.5 pp |
| FY2018 | -72.6% | -72.4 pp |
| FY2017 | -0.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice